Ibnsina Pharma (Egypt) Probability of Future Stock Price Finishing Over 8.63

ISPH Stock   6.72  0.18  2.61%   
Ibnsina Pharma's future price is the expected price of Ibnsina Pharma instrument. It is based on its current growth rate as well as the projected cash flow expected by the investors. This tool provides a mechanism to make assumptions about the upside potential and downside risk of Ibnsina Pharma performance during a given time horizon utilizing its historical volatility. Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
  
Please specify Ibnsina Pharma's target price for which you would like Ibnsina Pharma odds to be computed.

Ibnsina Pharma Target Price Odds to finish over 8.63

The tendency of Ibnsina Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current PriceHorizonTarget PriceOdds to move over  8.63  or more in 90 days
 6.72 90 days 8.63 
near 1
Based on a normal probability distribution, the odds of Ibnsina Pharma to move over  8.63  or more in 90 days from now is near 1 (This Ibnsina Pharma probability density function shows the probability of Ibnsina Stock to fall within a particular range of prices over 90 days) . Probability of Ibnsina Pharma price to stay between its current price of  6.72  and  8.63  at the end of the 90-day period is about 5.33 .
Assuming the 90 days trading horizon Ibnsina Pharma has a beta of 0.0497. This usually indicates as returns on the market go up, Ibnsina Pharma average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Ibnsina Pharma will be expected to be much smaller as well. Moreover Ibnsina Pharma has an alpha of 1.0709, implying that it can generate a 1.07 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta).
   Ibnsina Pharma Price Density   
       Price  

Predictive Modules for Ibnsina Pharma

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Ibnsina Pharma. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.

Ibnsina Pharma Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. Ibnsina Pharma is not an exception. The market had few large corrections towards the Ibnsina Pharma's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Ibnsina Pharma, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Ibnsina Pharma within the framework of very fundamental risk indicators.
α
Alpha over Dow Jones
1.07
β
Beta against Dow Jones0.05
σ
Overall volatility
0.98
Ir
Information ratio 0.24

Ibnsina Pharma Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Ibnsina Pharma for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Ibnsina Pharma can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
Ibnsina Pharma appears to be risky and price may revert if volatility continues

Ibnsina Pharma Technical Analysis

Ibnsina Pharma's future price can be derived by breaking down and analyzing its technical indicators over time. Ibnsina Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Ibnsina Pharma. In general, you should focus on analyzing Ibnsina Stock price patterns and their correlations with different microeconomic environments and drivers.

Ibnsina Pharma Predictive Forecast Models

Ibnsina Pharma's time-series forecasting models is one of many Ibnsina Pharma's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Ibnsina Pharma's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.

Things to note about Ibnsina Pharma

Checking the ongoing alerts about Ibnsina Pharma for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Ibnsina Pharma help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Ibnsina Pharma appears to be risky and price may revert if volatility continues